Ignite Creation Date:
2025-12-25 @ 1:28 AM
Ignite Modification Date:
2025-12-30 @ 11:28 AM
Study NCT ID:
NCT01215994
Status:
UNKNOWN
Last Update Posted:
2015-04-21
First Post:
2010-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Estimation of Glomerular Filtration Rate (GFR) in Patients With Type 2 Diabetes Mellitus.
Sponsor:
AHEPA University Hospital
Organization:
Study Overview
Official Title:
Comparative Study of New Formulae of GFR Estimation Based on Creatinine, Cystatin C and Cr51-EDTA.
Status:
UNKNOWN
Status Verified Date:
2015-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the present study is to evaluate bias, precision and accuracy of new cystatin C and creatinine based equations for GFR estimation compared with 51Cr-EDTA (chromium-51 labeled ethylenediamine tetraacetic acid) measured GFR in patients with diabetes.
Detailed Description:
The purpose of the present study is to evaluate bias, precision and accuracy of new cystatin C and creatinine based equations for GFR estimation compared with 51Cr-EDTA measured GFR in patients with diabetes.
Additional, we will check which equation detects better the reduction of renal function over the time, in patients with diabetes.
Finally, we will investigate if cystatin C levels can be influenced by factors other than GFR
Additional, we will check which equation detects better the reduction of renal function over the time, in patients with diabetes.
Finally, we will investigate if cystatin C levels can be influenced by factors other than GFR
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: